Related Experiment Video
Updated: Apr 28, 2026
07:05
A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
Published on: August 24, 2017
13.7K
Does melatonin have therapeutic use in tinnitus?
Leah Merrick1, Dima Youssef1, Michelle Tanner1
1From the Sycamore Shoals Hospital, Elizabethton, the Department of Internal Medicine, Division of Infectious Diseases, and the James H. Quillen College of Medicine, East Tennessee State University, and the Department of Medicine, Mountain Home Veterans Affairs Medical Center, Johnson City, Tennessee.
Southern Medical Journal
|June 20, 2014
Summary
Melatonin, a sleep hormone, shows promise for tinnitus relief. It may help alleviate symptoms and protect hearing, offering a safe option for patients.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Melatonin is a hormone regulating sleep-wake cycles.
- Tinnitus is a common condition with limited treatment options.
- Melatonin's potential role in tinnitus management is under investigation.
Purpose of the Study:
- To explore melatonin as a potential therapeutic agent for tinnitus.
- To review melatonin's known physiological effects and proposed mechanisms in tinnitus.
Main Methods:
- Review of existing scientific literature on melatonin and tinnitus.
- Analysis of melatonin's antioxidative and sleep-promoting properties.
- Evaluation of safety and tolerability data for melatonin supplementation.
Main Results:
- Melatonin may alleviate subjective tinnitus symptoms.
- Potential protective effects against ototoxic agents observed.
- Antioxidative properties demonstrated in vitro, though at supraphysiologic levels.
- Sleep enhancement is a likely mechanism of benefit.
- Minimal toxicity risk with low daily doses (1-3 mg).
Conclusions:
- Melatonin is a low-risk, cost-effective option for tinnitus management.
- Further consideration of melatonin for patients with significant tinnitus is recommended.
- Potential neurogenerative properties warrant additional research.
Related Concept Videos
01:19Management of Insomnia
768
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
768
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
960
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
960
01:16Therapeutic Drug Monitoring: Overview and Classification
635
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
635
01:23Sedatives and Hypnotics: Overview
2.3K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.3K
01:29Therapeutic Drug Monitoring: Affecting Factors
428
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
428